Advertisement
Conference Highlights: ADA 2016

Conference Highlights: ADA 2016

CV Events & Mortality in Diabetes Few large studies have assessed the impact of cardiovascular (CV) events on mortality in patients with type 2 diabetes. To address this research gap, investigators evaluated the risk of a CV-related death in a large group of patients with type 2 diabetes at very high CV risk and in those who experienced a major non-fatal CV event . Patients who had experienced a non-fatal CV event had a higher risk of CV-related mortality. When compared with patients who did not experience a non-fatal CV event, adjusted hazard ratios for mortality were: 3.12 after myocardial infarction. 4.96 after heart failure. 3.08 after stroke. —————————————————————-   Glycemic Control Reduces Retinopathy Risk Previous research has demonstrated the positive effect of intensive glycemic control on the progression of retinopathy in patients who are newly diagnosed with diabetes. Whether this effect occurs in patients who have been diagnose with diabetes for 10 years has yet to be determined. The impact of 3.7 years of tight glycemic control on retinopathy risk was assessed in patients with type 2 diabetes for a study. Diabetic retinopathy had progressed three or more steps on the Early Treatment Diabetic Retinopathy Study scale 8 years after a baseline exam among 12.7% who achieved standard glycemic control, compared with a rate of 5.8% that was observed among those achieving more intense glycemic control. —————————————————————- Assessing Transitional Care Interventions for Older Diabetics Transitional care interventions—including diabetes self-management education (DSME) and home visits—have been shown in prior studies to help improve outcomes for patients with diabetes. However, comparisons of outcomes following inpatient DSME versus inpatient DSME plus...
[ HIDE/SHOW ]